Induction of resistance in mice by the capsular polysaccharide antigens of Staphylococcus aureus
- PMID: 3125414
- DOI: 10.1111/j.1348-0421.1987.tb03125.x
Induction of resistance in mice by the capsular polysaccharide antigens of Staphylococcus aureus
Abstract
Mice actively immunized with capsular polysaccharides extracted from capsular type strains A, B, C, and D, determined by the serum-soft agar technique, were protected against lethal infection by homologous strains, but no animals survived infection by heterologous substance immunization even with at high doses. Passive protective antibody in rabbit antisera prepared using these strains was absorbed out only by homologous capsular polysaccharide in mice. These results indicated that resistance was specific for capsular polysaccharide. The substance contained mainly neutral sugar, small amounts of hexosamine, methyl-pentose, and phosphate although these amounts varied depending on the capsular types strains.
Similar articles
-
Protection of mice by a pseudodiffuse strain of Staphylococcus aureus possessing polyvalent capsular type antigen.J Med Microbiol. 1989 Feb;28(2):129-36. doi: 10.1099/00222615-28-2-129. J Med Microbiol. 1989. PMID: 2915365
-
Purified capsular polysaccharide-induced immunity to Staphylococcus aureus infection.J Infect Dis. 1988 Apr;157(4):723-30. doi: 10.1093/infdis/157.4.723. J Infect Dis. 1988. PMID: 3346565
-
Cross protection between an encapsulated strain of Staphylococcus hyicus and encapsulated strains of Staphylococcus aureus.J Appl Bacteriol. 1988 Dec;65(6):491-9. doi: 10.1111/j.1365-2672.1988.tb01922.x. J Appl Bacteriol. 1988. PMID: 3243729
-
Use of a conjugate polysaccharide vaccine in the prevention of invasive staphylococcal disease: is an additional vaccine needed or possible?Vaccine. 2006 Apr 12;24 Suppl 2:S2-65-9. doi: 10.1016/j.vaccine.2005.01.126. Vaccine. 2006. PMID: 16823932 Review.
-
Vaccine potential of poly-1-6 beta-D-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis.J Biotechnol. 2000 Sep 29;83(1-2):37-44. doi: 10.1016/s0168-1656(00)00296-0. J Biotechnol. 2000. PMID: 11000458 Review.
Cited by
-
Integrating complex host-pathogen immune environments into S. aureus vaccine studies.Cell Chem Biol. 2022 May 19;29(5):730-740. doi: 10.1016/j.chembiol.2022.04.003. Cell Chem Biol. 2022. PMID: 35594849 Free PMC article. Review.
-
Non-protective immune imprint underlies failure of Staphylococcus aureus IsdB vaccine.Cell Host Microbe. 2022 Aug 10;30(8):1163-1172.e6. doi: 10.1016/j.chom.2022.06.006. Epub 2022 Jul 7. Cell Host Microbe. 2022. PMID: 35803276 Free PMC article.
-
Outermost-cell-surface changes in an encapsulated strain of Staphylococcus aureus after preservation by freeze-drying.Appl Environ Microbiol. 1988 Oct;54(10):2486-91. doi: 10.1128/aem.54.10.2486-2491.1988. Appl Environ Microbiol. 1988. PMID: 3202630 Free PMC article.
-
Comparison of compact colony-forming activity and paracoagulation activity of strains of Staphylococcus aureus in serum and plasmas of various animals.Med Microbiol Immunol. 1988;177(6):323-31. doi: 10.1007/BF02389904. Med Microbiol Immunol. 1988. PMID: 3216814
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical